Approved conversion of 7,35,000 Warrants into Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Shelter Pharma Ltd, at its meeting on November 15, 2025, approved the conversion of 7,35,000 convertible warrants into 7,35,000 fully paid equity shares of face value ₹10 each. The warrants were originally issued on August 6, 2025 at an issue price of ₹42.25 per warrant (including a ₹32.25 premium). All three allottees are non-promoter individuals, and they paid the remaining 75% balance of ₹31.6875 per share, aggregating to ₹2.33 crore. As a result, the company's paid-up equity capital has risen from ₹14.86 crore (1.48 crore shares) to ₹15.60 crore (1.56 crore shares), a dilution of about 4.9%.
This is a routine warrant-to-equity conversion, not fresh fundraising. The ₹2.33 crore inflow comes from existing warrant holders completing their committed investment. Shareholders face mild dilution (~4.9%), but since these shares were already anticipated at the time of warrant issuance, the immediate stock impact should be limited.